These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11450917)

  • 1. 1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2.
    Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL
    ANZ J Surg; 2001 Jul; 71(7):414-7. PubMed ID: 11450917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; Birkenhäger JC; van Leeuwen JP
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells.
    Chiang KC; Persons KS; Istfan NW; Holick MF; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3591-6. PubMed ID: 19667153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
    Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung.
    Ormerod AK; Xing Z; Pedigo NG; Mishra A; Kaetzel DM
    Exp Lung Res; 2008 May; 34(4):155-82. PubMed ID: 18432454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
    Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2.
    Pourgholami MH; Akhter J; Finlay IG; Morris DL
    Anticancer Res; 2000; 20(2A):723-7. PubMed ID: 10810346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C; Mathiasen IS; James SY; Nayeri S; Bretting C; Hansen CM; Colston KW; Carlberg C
    J Cell Biochem; 1997 Sep; 66(4):552-62. PubMed ID: 9282333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells.
    Xie SP; James SY; Colston KW
    J Endocrinol; 1997 Sep; 154(3):495-504. PubMed ID: 9379127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
    Yu J; Papavasiliou V; Rhim J; Goltzman D; Kremer R
    Anticancer Drugs; 1995 Feb; 6(1):101-8. PubMed ID: 7756673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells.
    Oh YS; Kim EJ; Schaffer BS; Kang YH; Binderup L; MacDonald RG; Park JH
    Mol Cell Endocrinol; 2001 Oct; 183(1-2):141-9. PubMed ID: 11604234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
    van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
    Simboli-Campbell M; Narvaez CJ; van Weelden K; Tenniswood M; Welsh J
    Breast Cancer Res Treat; 1997 Jan; 42(1):31-41. PubMed ID: 9116316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation.
    Lin R; Nagai Y; Sladek R; Bastien Y; Ho J; Petrecca K; Sotiropoulou G; Diamandis EP; Hudson TJ; White JH
    Mol Endocrinol; 2002 Jun; 16(6):1243-56. PubMed ID: 12040012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
    James SY; Mackay AG; Binderup L; Colston KW
    J Endocrinol; 1994 Jun; 141(3):555-63. PubMed ID: 8071654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.